A novel in vitro semiquantitative method was developed to investigate the influence of staphylococcal slime on the activities of 22 antimicrobial agents. Pefloxacin, teicoplanin, and vancomycin demonstrated remarkable decreases in efficacy: 30, 52, and 63%, respectively. The activity of rifampin was not significantly reduced (0.99%), whereas all other agents tested were modestly affected (<15% decrease). These data could be influential in the treatment of implant-associated infections caused by slime-producing staphylococci.
pore-size sterile cellulose filters (Millipore Corporation, Bedford, Mass.) placed on staphylococcus agar no. 110 plates. An adherent biofilm was visible on the surface of each filter after 24 h of incubation. To remove nonadherent bacteria, each filter was eluted in tryptic soy broth. The remaining slime was collected with a sterile loop, mixed with 40 l of each antimicrobial solution, and transferred into wells of specially prepared Mueller-Hinton agar (Becton Dickinson) plates preseeded with Bacillus subtilis spores (MD32SDR). An equal volume (40 l) of each antimicrobial solution without slime was placed in an additional well and used as a relevant control. Since the strains were exposed to the same environmental conditions across all experiments, the quantity of slime produced by each strain was considered to be constant (4) . The suspensions used in each experiment were of standard volume, and all the wells were filled to the rim. Following a 24-h incubation, inhibition zone diameters were measured. Each experiment was simultaneously done in triplicate, and each time, samples (antibiotic with slime from each strain) and the relevant controls were placed in random places on the plate in order to eliminate the edge effect and other possible gradients across the plates.
In performing the statistical analysis, we calculated the difference between the average of the three measurements for each strain and the average control value and then tested whether these differences were statistically significant by the Wilcoxon signed rank test. In order to summarize the effects of slime on various antibiotics, we calculated the percent difference of each sample (antibiotic with slime from each strain) from the relevant control and took the average across the 26 strains as the percent reduction in the effectiveness of the antibiotic.
The results of the study are summarized in Table 2 . Although the literature contains reports that argue against the presence of an antibiotic diffusion barrier in biofilms (7, 24) , our results suggest that staphylococcal slime is responsible for a significant decrease in the efficacy of certain antimicrobial agents, whereas its effect is minimal for others.
Vancomycin is the drug of choice for the treatment of infections caused by methicillin-resistant staphylococci (14) . However, our findings as well as data from previous reports (7, 9-11, 28, 31) suggest that the glycopeptides may not be the optimal antimicrobial agents for the treatment of foreign-body infections. A possible explanation could be the entrapment of vancomycin and teicoplanin by the extracellular mucopolysaccharide because of their high molecular weights (MWs) (1,450 and 1,600 to 1,900, respectively). These agents have higher MWs than most of the agents used in this study (range of MWs, 360 to 830). However, this explanation should exclude daptomycin, which also shares a rather high MW (1,619) but was shown to be less influenced by staphylococcal slime. Our efforts to correlate the hydrophobicities or the charges of the antibiotic molecules tested with the reductions in effectiveness produced by slime were unsuccessful, although these physicochemical properties could partly explain the reduced permeabilities of certain antibiotics through biofilms (12, 19) .
We have shown that the presence of slime did not influence the activity of rifampin and had minimal influence on the activities of clindamycin and the macrolides. There is evidence to suggest that slime itself interferes with local host defenses and creates conditions of local immunosuppression (15, 26) . Therefore, bacteriostatic agents such as the macrolides may not be the agents of choice for the treatment of these infections. Rifampin is a bactericidal agent with a high level of intrinsic activity against staphylococci and could be active against methicillin-resistant staphylococci (14) . It also remains very potent in the presence of slime, as confirmed by other related in vitro and in vivo studies (8, 9, 21, 28, 31) , suggesting that it would be an indispensable agent in combination regimens for the treatment of prosthetic-device infections. In view of the data presented in Table 2 , we could conclude that among the tested agents the ␤-lactams, trimethoprim-sulfamethoxazole, the aminoglycosides, and the quinolones, with the exception of pefloxacin, would be potent alternatives in combination regimens for the treatment of prosthetic-device infections.
Recently, several publications have focused on the in vitro use of electric fields to enhance the penetration of antibiotics through microbial biofilms (5, 25, 27) . Until this approach finds its application in clinical practice, the successful treatment of device-related infections will depend on the prudent use of antibiotics and surgery. The findings of this in vitro study may be influential in the appropriate use of antibiotics for the treatment of implant-associated infections caused by slimeproducing staphylococci. This is of the utmost importance, especially for debilitated patients who cannot undergo surgical removal of the infected foreign body.
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